A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. - Wikidata - awgldk - TriplyDB

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

http://www.wikidata.org/entity/Q35084573

about

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders Role of MYC in B Cell Lymphomagenesis.Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.Paediatric non-Hodgkin lymphoma - perspectives in translational biology The 2016 revision of the World Health Organization classification of lymphoid neoplasms.The transcription factor ETS1 in lymphomas: friend or foe?EBV-associated Burkitt lymphoma in Taiwan is not age-related.Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.Lymphoma classification update: B-cell non-Hodgkin lymphomas.The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects 2016 WHO Classification update-What's new in lymphoid neoplasms.Diagnosis and classification of hematologic malignancies on the basis of genetics.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma.Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.Aggressive lymphoma 2016: revision of the WHO classification.MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.The clinicopathologic spectrum of mature aggressive B cell lymphomas.A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry.Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.The 2016 updated WHO classification of lymphoid neoplasias.

P2860

Q26785379-1E120E2A-B493-4672-9BAC-FEE74F95EEF5 Q28075701-D2AA8C76-DCFC-4E7E-AE69-BAD5D1765E8D Q33608499-9AC8F7BE-6D0C-426D-BBE9-2BBFE67C008A Q33729711-9FBC7C1C-6F94-4D46-B2F5-9BD3BCE3FC6B Q35881523-F37A8764-82A6-4651-B3F8-6CA9A67B69D1 Q36103110-02621DE3-56F0-4F18-8E5E-812EDCF16C28 Q36143915-86BD5F71-F26C-4B62-966E-F23980A4AD21 Q36889143-D2919B2F-1EF7-4DAB-B539-966F51742EA3 Q36920426-E7389E3C-BA42-4008-915B-E3E5DE73B711 Q38264349-F2830304-801C-4023-B373-997258B8C602 Q38595746-FA25504E-CAA7-4703-A9D5-B4791FD3010C Q38663689-F3D2D458-D694-404D-8689-593F49883967 Q38771110-07FB84BB-B9A7-433D-BE02-B7FF7D10E16F Q38780780-EB56B89D-6CAB-4C7C-ABFE-D8BFF166DE71 Q38798801-1833C6FA-295D-4669-A851-1A05E8E09D67 Q38843988-95A49728-DFF8-4894-8B4E-4250093FC09F Q39221506-8E501AE9-FFBC-4A0F-9218-EF91F525E257 Q39266295-45CB45BD-B6A9-49C2-A2D5-36A7D467A475 Q39363409-E0FEFB10-1E14-46F2-A4E5-F35274593ADC Q39406673-D04847C1-27C4-4EB9-B85B-B571D7B39EA0 Q40316913-2C806497-D82D-463C-BE7C-446D54ECFCB6 Q40331337-8D84B74E-C83F-47EF-9DDA-08DA5AD2B5F0 Q42357206-B5A3E09A-7F42-495F-9CBF-1976DD408830 Q42384503-7753AC43-A644-45CD-BEC9-DA71D23B6655 Q47123563-2A8B0CD2-CFB9-4FE7-A91A-95BEADB36A3A Q47215137-3B59FEF5-3154-44FE-8168-C82DC54870D8 Q48170832-363037B6-DEAF-48D0-B19B-370C678D301C Q48254769-686E0D01-CABF-43B8-92A9-181B0C4A7C20 Q48338600-7C78CEF8-6DC2-4C50-8E4F-CD546EECBF67 Q49612944-EFA705B0-386E-4F4F-AE08-489154592B91 Q51735191-4A2092E8-252E-4DA7-894A-AAAE95EF0367 Q52547022-E4371A0B-95E9-4CE1-B419-49E73848A2F6 Q52899841-5F71A0B8-5C6F-4CA1-9C82-F9AAE8953EBE Q53618163-3A920CBB-2C9E-442E-BCB8-94A400A0C71C Q54208432-9E724CDA-4A78-426A-9883-3CE959E87242

P2860

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

http://www.wikidata.org/entity/Q35084573

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@ast

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@en

type

label

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@ast

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@en

prefLabel

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@ast

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@en

P1433

Q35084573-23D72020-E334-4BEE-B52C-BC565DB3A759

P1476

Q35084573-ADC8C268-C301-45D1-A2C2-C6A25A3D4399

P2093

Q35084573-0301BE93-1CE2-48D4-B5CF-96A6C3FC3D1C

Q35084573-03F21D20-BEE0-464E-855C-661988B16C9D

Q35084573-13C564B1-F9E7-4DB6-BAC3-2858B30BF8A2

Q35084573-1D9F892F-BDBF-4DDC-8F57-8FEA390233EF

Q35084573-323E2140-309D-49E9-879F-081ED512BBBC

Q35084573-39B7CCCE-002E-4B01-96C8-E3DFC9DE1A6A

Q35084573-448AA0BC-B7AD-44E3-B5A0-0A4E4F760F03

Q35084573-46742CC2-151E-4EC4-90DB-14CD68AE7E71

Q35084573-517C312B-4EFE-4F38-814A-87E1CB437DF1

Q35084573-689C54EA-A72B-45D6-AC01-99FFA8395F3B

P2860

Q35084573-0A403136-1C8C-44E0-A2A8-1BC85A453C04

Q35084573-1217F2E8-505A-4F27-827E-42C1345DD42C

Q35084573-12A7C8E9-9698-41CA-AF64-A2E862A24F9F

Q35084573-144AB94A-3ACF-4FB1-833A-DA65E23DACBD

Q35084573-17652D41-91A2-4E6C-84D4-60D13623E00D

Q35084573-1B53B1C2-2088-4972-BA45-737E349E6BE4

Q35084573-1F8EBD60-EF6F-47BA-961C-73EEFD437E5A

Q35084573-238E7FBC-B1D5-416C-AD84-9002424043BD

Q35084573-241AE26B-16D6-4EC4-9CC4-0C1582324672

Q35084573-24D92270-ADBA-4FB9-9A89-215A79FA8824

P304

Q35084573-15C51083-8AE8-4290-BD2C-9EE7EFA0CB62

P31

Q35084573-BA036D1A-44B6-46A7-8F11-69B3AD8DC173

P356

Q35084573-CCBA21AD-63EC-4D8B-B24A-B79BDF7D4D13

P407

Q35084573-BF027C7A-3E1E-40F9-8E0B-38AB15A2386D

P433

Q35084573-05EB2F0A-6E33-4E96-B0DB-58C49198AA9C

P478

Q35084573-BFEDA50C-018E-4BE8-93C9-FD02140A77C9

P50

Q35084573-2AA1C5E9-7AFD-4788-86AA-D5E3A813B1BA

Q35084573-2B1E3309-85D2-4004-AED3-7463ABCD3AB8

Q35084573-45FCBFA2-98E3-4ABC-A167-BB96DB969ED4

Q35084573-486E1D36-919E-42E5-B8C4-F7126E047B77

Q35084573-4985A8D3-748C-43BB-A588-3AA4366F4F87

Q35084573-53580876-23D6-43C7-82AB-0C00E1D73272

Q35084573-6B40EB6B-CC05-4283-BEF3-39DBCB94F3EE

Q35084573-6F4C492B-DCBC-4B59-BDCD-9109DFF911B6

Q35084573-71F19BBB-46D9-4787-9E72-6C89DB5D3ED3

Q35084573-763CB469-005D-49F5-BB13-9B3F397D0D5A

P577

Q35084573-E0F23B5E-C2A6-4503-A76D-A57F801A9834

P5875

Q35084573-DD68574B-2ACA-41C7-A333-CE7ECE750525

P698

Q35084573-E1F42CDB-F9C8-49CE-91A9-5A594613675F

P921

Q35084573-59123A95-B449-486B-BF78-4F6A3B8CDFE0

P932

Q35084573-FAD0092B-A573-4CE2-9B59-5951FDF2631C

P356

BLOOD-2013-06-507996

P1433

P1476

A recurrent 11q aberration pat ...... s resembling Burkitt lymphoma.

@en

P2093

Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group

http://www.w3.org/2001/XMLSchema#string

Birgit Burkhardt

http://www.w3.org/2001/XMLSchema#string

Carsten Schwaenen

http://www.w3.org/2001/XMLSchema#string

Christian W Kohler

http://www.w3.org/2001/XMLSchema#string

Christine Damm-Welk

http://www.w3.org/2001/XMLSchema#string

Detlev Schindler

http://www.w3.org/2001/XMLSchema#string

Grzegorz Rymkiewicz

http://www.w3.org/2001/XMLSchema#string

Idoia Martin-Guerrero

http://www.w3.org/2001/XMLSchema#string

Ilske Oschlies

http://www.w3.org/2001/XMLSchema#string

Inga Nagel

http://www.w3.org/2001/XMLSchema#string

P2860

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma

A human protein-protein interaction network: a resource for annotating the proteome

Cooperative epigenetic modulation by cancer amplicon genes

The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Molecular analysis of an unstable genomic region at chromosome band 11q23 reveals a disruption of the gene encoding the alpha2 subunit of platelet-activating factor acetylhydrolase (Pafah1a2) in human lymphoma

The genetic landscape of mutations in Burkitt lymphoma.

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials.

Molecular biology of Burkitt's lymphoma.

P304

1187-1198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2013-06-507996

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Robert B. Russell

Barbara Pienkowska-Grela

Itziar Salaverria

Alexander Claviez

Lorenz Trümper

Monika Szczepanowski

René Scholtysik

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259626777

http://www.w3.org/2001/XMLSchema#string

P698

24398325

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

P932

3931189

http://www.w3.org/2001/XMLSchema#string